These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12023098)

  • 1. Using alternative methodologies for evaluating patient medication leaflets.
    Krass I; Svarstad BL; Bultman D
    Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of written medicine information: validation of the Consumer Information Rating Form.
    Koo MM; Krass I; Aslani P
    Ann Pharmacother; 2007 Jun; 41(6):951-6. PubMed ID: 17488832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.
    Raynor DK; Svarstad B; Knapp P; Aslani P; Rogers MB; Koo M; Krass I; Silcock J
    J Am Pharm Assoc (2003); 2007; 47(6):717-24. PubMed ID: 18032134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of patient information leaflets incorporating patient diversity considerations: Varicocele embolisation and fluoroscopy guided joint injection examinations.
    Vassallo T; Mizzi A; Depasquale R; Maher M; Rainford L
    Radiography (Lond); 2018 Oct; 24 Suppl 1():S20-S27. PubMed ID: 30166004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient information leaflets for antidepressants: are patients getting the information they need?
    Haw C; Stubbs J
    J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Readability of Dermatological Postoperative Patient Information Leaflets Across England.
    Hunt WT; McGrath EJ
    Dermatol Surg; 2016 Jun; 42(6):757-63. PubMed ID: 27176870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review.
    Tong V; Raynor DK; Aslani P
    Int J Clin Pharm; 2014 Oct; 36(5):865-72. PubMed ID: 24980281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and psychometric validation for evaluating written medicine information in Thailand: The Consumer Information Rating Form.
    Wongtaweepkij K; Krska J; Pongwecharak J; Pongpunna S; Jarernsiripornkul N
    BMJ Open; 2021 Oct; 11(10):e053740. PubMed ID: 34598992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient information leaflets and package inserts of ibuprofen provided in the UK and Thailand: a comparative assessment.
    Nualdaisri P; Corlett SA; Krska J
    Int J Pharm Pract; 2024 May; 32(3):208-215. PubMed ID: 38442896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the quality of medication information for patients in Spain.
    Mira JJ; Lorenzo S; Pérez-Jover V; Navarro I; Martín de Rosales AM; Lara C
    Expert Opin Drug Saf; 2013 Jan; 12(1):9-18. PubMed ID: 23228060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge.
    Jarernsiripornkul N; Phueanpinit P; Pongwecharak J; Krska J
    PLoS One; 2019; 14(1):e0210395. PubMed ID: 30625196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient information: community pharmacy needs and perspectives.
    Juergens JP; Basara LR
    Top Hosp Pharm Manage; 1994 Oct; 14(3):47-57. PubMed ID: 10138928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Australian dermatological postoperative patient information leaflets: Should we have a national checklist?
    Hunt WT; O'Sullivan NA; Donnelly A
    Australas J Dermatol; 2018 May; 59(2):118-123. PubMed ID: 28425573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consumer medication leaflets inadequate, FDA says.
    Traynor K
    Am J Health Syst Pharm; 2009 Feb; 66(3):208, 210. PubMed ID: 19179632
    [No Abstract]   [Full Text] [Related]  

  • 17. How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
    Burgers C; Beukeboom CJ; Sparks L; Diepeveen V
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):137-43. PubMed ID: 25044310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thai Patients' Drug Safety Knowledge and Perceptions Relating to Different Forms of Written Medicine Information: A Comparative Study.
    Wongtaweepkij K; Krska J; Pongpunna S; Pongwecharak J; Jarernsiripornkul N
    Patient Prefer Adherence; 2022; 16():1141-1152. PubMed ID: 35517042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Written medicine information from English-speaking countries--how does it compare?
    Luk A; Tasker N; Raynor DK; Aslani P
    Ann Pharmacother; 2010 Feb; 44(2):285-94. PubMed ID: 20103613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of patient information leaflet and perceived impact of its use on medication adherence.
    Al Jeraisy M; Alshammari H; Albassam M; Al Aamer K; Abolfotouh MA
    BMC Public Health; 2023 Mar; 23(1):488. PubMed ID: 36918823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.